Holen Sie sich die Stockscreener-App
1.71
0.59%
0.01
Handel nachbörslich:
1.71
Schlusskurs vom Vortag:
$1.70
Offen:
$1.66
24-Stunden-Volumen:
40,906
Relative Volume:
0.83
Marktkapitalisierung:
$9.46M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.29M
KGV:
-0.4286
EPS:
-3.99
Netto-Cashflow:
$-12.27M
1W Leistung:
+4.27%
1M Leistung:
-1.16%
6M Leistung:
-51.56%
1J Leistung:
-48.18%
1-Tages-Spanne:
$1.66
$1.73
1-Wochen-Bereich:
$1.55
$1.7849
52-Wochen-Spanne:
$1.412
$5.01
Aprea Therapeutics Inc Stock (APRE) Company Profile
Firmenname
Aprea Therapeutics Inc
Sektor
Branche
Telefon
215-948-4119
Adresse
3805 OLD EASTON ROAD, DOYLESTOWN, MA
Vergleichen Sie APRE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APRE
Aprea Therapeutics Inc
|
1.71 | 9.40M | 0 | -14.29M | -12.27M | -3.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Aprea Therapeutics Inc Stock (APRE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-12-28 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-12-16 | Eingeleitet | Berenberg | Buy |
| 2020-09-29 | Fortgesetzt | JP Morgan | Neutral |
| 2020-06-22 | Eingeleitet | H.C. Wainwright | Neutral |
| 2020-04-21 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-10-28 | Eingeleitet | JP Morgan | Neutral |
| 2019-10-28 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2019-10-28 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Aprea Therapeutics Inc Aktie (APRE) Neueste Nachrichten
Aprea Therapeutics Inc.’s volatility index tracking explainedJuly 2025 EndofMonth & Weekly Momentum Stock Picks - Newser
What’s the recovery path for long term holders of Aprea Therapeutics Inc.July 2025 Breakouts & Detailed Earnings Play Strategies - Newser
Combining price and volume data for Aprea Therapeutics Inc.Weekly Gains Report & Verified Momentum Stock Alerts - Newser
Aprea Therapeutics 2025 Q2 Earnings Loss Narrows as Net Income Improves 6.7% - AInvest
Aprea Therapeutics Reports Promising Q2 2025 Results - TipRanks
What’s next for Aprea Therapeutics Inc. stock priceMomentum Prediction Based on AI Backtesting - Newser
Real time social sentiment graph for Aprea Therapeutics Inc.Portfolio Risk Distribution Analysis Tool - Newser
Quantitative breakdown of Aprea Therapeutics Inc. recent moveFree Trade Setups With AI Powered Filters - Newser
Is it too late to sell Aprea Therapeutics Inc.Weekly Trend Watch with Market Signals - Newser
Analyzing drawdowns of Aprea Therapeutics Inc. with statistical toolsFree Short Term Trading Opportunity Watch - Newser
How to forecast Aprea Therapeutics Inc. trends using time seriesFree Early Entry Picks Before News Breakout - Newser
How hedge fund analytics apply to Aprea Therapeutics Inc. stockMulti-Year Investment Performance Summary Report - Newser
Aprea Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Aprea Therapeutics, Inc. SEC 10-Q Report - TradingView
Aprea Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Clinical Update - The Manila Times
Aprea Therapeutics Inc. stock retracement – recovery analysisStock Market Watch with Smart Filters - Newser
Why Aprea Therapeutics Inc. stock attracts strong analyst attentionInsider Strategy for High Conviction Picks - Newser
Published on: 2025-08-11 23:58:33 - Newser
How Aprea Therapeutics Inc. stock performs during market volatilityNeural Network Based Equity Prediction System - Newser
How to interpret RSI for Aprea Therapeutics Inc. stockFree Daily Stock Market Swing Alerts - Newser
Long term hold vs stop loss in Aprea Therapeutics Inc.Free Weekly Return Pick Forecast Reports - Newser
Is Aprea Therapeutics Inc. meeting your algorithmic filter criteriaMarket Opportunity Tracker for Swing Traders - Newser
Signal strength of Aprea Therapeutics Inc. stock in tech scannersExit Strategy Guide With Risk Control Plan - Newser
Is Aprea Therapeutics Inc. forming a bottoming baseTechnical Trend Forecast for Investors - Newser
Can you recover from losses in Aprea Therapeutics Inc.Rapid Trade Forecast Based on Indicators - Newser
Is Aprea Therapeutics Inc. Stock Overbought or Oversold RSI Indicator AnalysisFree Real Time Trade Opportunity Alerts - Newser
Buy Signal for Aprea Therapeutics Inc. Stock Key Technical Indicators to WatchMomentum Screener with Buy and Sell Areas - Newser
Multi asset correlation models including Aprea Therapeutics Inc.Entry Confirmation Based on Volatility Analysis - Newser
What candlestick patterns are forming on Aprea Therapeutics Inc.Free Early Entry Tips With Low Risk Zone - Newser
Aprea Therapeutics (APRE) to Release Quarterly Earnings on Monday - Defense World
Strategies to average down on Aprea Therapeutics Inc.Swing Reversal Forecast Based on Patterns - Newser
Aprea Therapeutics APRE 2025Q2 Earnings Preview Upside Potential Amid Breakthrough Therapy Designation - AInvest
Key resistance and support levels for Aprea Therapeutics Inc.Buy Opportunity Forecast for Fast Traders - Newser
Applying Wyckoff theory to Aprea Therapeutics Inc. stockTrading Opportunities Forecast by AI Insight - Newser
Trend analysis for Aprea Therapeutics Inc. this week3-Day Market Movement Forecast Analysis - Newser
Finanzdaten der Aprea Therapeutics Inc-Aktie (APRE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):